Third Drug Approved for Metastatic, Treatment-Resistant GIST

Regorafenib, a multikinase inhibitor, has been approved as a treatment for locally advanced, unresectable, or metastatic gastrointestinal stromal tumor in people who have been treated with imatinib and...
Source: OncologySTAT Latest News - Category: Cancer & Oncology Source Type: news